CAPTRUST Financial Advisors’s Treace Medical Concepts TMCI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$208K	Buy	52,265 +23,378	+81%	+$64.3K	﹤0.01%	2854
2026 Q1	$38.7K	Buy	28,887 +10,887	+60%	+$21.7K	﹤0.01%	2920
2025 Q4	$44.1K	Buy	18,000 +3,365	+23%	+$14.6K	﹤0.01%	2687
2025 Q3	$98.2K	Buy	14,635 +4,070	+39%	+$26.6K	﹤0.01%	2513
2025 Q2	$62.1K	Buy	+10,565	New	+$68.8K	﹤0.01%	2410
2024 Q1	–	Sell	-35,697	Closed	-$455K	–	2628
2023 Q4	$455K	Sell	35,697 -23,348	-40%	-$236K	﹤0.01%	1798
2023 Q3	$774K	Buy	59,045 +4,252	+8%	+$77.8K	﹤0.01%	1362
2023 Q2	$1.4M	Buy	+54,793	New	+$1.41M	0.01%	1000
2022 Q2	–	Sell	-64	Closed	-$1K	–	5145
2022 Q1	$1K	Sell	64 -17	-21%	-$330	﹤0.01%	4755
2021 Q4	$2K	Buy	+81	New	+$1.67K	﹤0.01%	4453

Other funds holding TMCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

CAPTRUST Financial Advisors's TMCI Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Treace Medical Concepts (TMCI) stake by 81% in Q2 2026, buying an estimated $64.3K and bringing the position to 52,265 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2854.

CAPTRUST Financial Advisors first reported a position in TMCI in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.4M in Q2 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

CAPTRUST Financial Advisors held 52,265 shares of Treace Medical Concepts worth $208K as of Q2 2026.
CAPTRUST Financial Advisors bought 23,378 Treace Medical Concepts shares in Q2 2026, an estimated $64.3K.
Treace Medical Concepts made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2854 holding.
CAPTRUST Financial Advisors first reported a position in Treace Medical Concepts in Q4 2021 and has held it in 10 quarters since.
CAPTRUST Financial Advisors's Treace Medical Concepts position peaked at $1.4M in Q2 2023.
117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.